These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Corsini A; Mazzotti M; Raiteri M; Soma MR; Gabbiani G; Fumagalli R; Paoletti R Atherosclerosis; 1993 Jun; 101(1):117-25. PubMed ID: 8216498 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Corsini A; Raiteri M; Soma MR; Bernini F; Fumagalli R; Paoletti R Am J Cardiol; 1995 Jul; 76(2):21A-28A. PubMed ID: 7604791 [TBL] [Abstract][Full Text] [Related]
7. Carvastatin suppresses intimal thickening of rabbit carotid artery after balloon catheter injury probably through the inhibition of vascular smooth muscle cell proliferation and migration. Komukai M; Wajima YS; Tashiro J; Shinomiya M; Saito Y; Morisaki N Scand J Clin Lab Invest; 1999 May; 59(3):159-66. PubMed ID: 10400160 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of fluvastatin at doses insufficient to lower serum lipids on the catheter-induced thickening of intima in rabbit femoral artery. Bandoh T; Mitani H; Niihashi M; Kusumi Y; Ishikawa J; Kimura M; Totsuka T; Sakurai I; Hayashi S Eur J Pharmacol; 1996 Nov; 315(1):37-42. PubMed ID: 8960862 [TBL] [Abstract][Full Text] [Related]
9. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase. Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861 [TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Lennernäs H; Fager G Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173 [TBL] [Abstract][Full Text] [Related]
11. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth. Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232 [TBL] [Abstract][Full Text] [Related]
12. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens. Mosley ST; Kalinowski SS; Schafer BL; Tanaka RD J Lipid Res; 1989 Sep; 30(9):1411-20. PubMed ID: 2513368 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types. Nègre-Aminou P; van Vliet AK; van Erck M; van Thiel GC; van Leeuwen RE; Cohen LH Biochim Biophys Acta; 1997 Apr; 1345(3):259-68. PubMed ID: 9150246 [TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Hsu I; Spinler SA; Johnson NE Ann Pharmacother; 1995; 29(7-8):743-59. PubMed ID: 8520093 [TBL] [Abstract][Full Text] [Related]
15. NK-104, a newly developed HMG-CoA reductase inhibitor, suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery. Kitahara M; Kanaki T; Toyoda K; Miyakoshi C; Tanaka S; Tamaki T; Saito Y Jpn J Pharmacol; 1998 Jun; 77(2):117-28. PubMed ID: 9681568 [TBL] [Abstract][Full Text] [Related]
16. Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver. Kocarek TA; Reddy AB Drug Metab Dispos; 1996 Nov; 24(11):1197-204. PubMed ID: 8937853 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of policosanol vs lovastatin on intimal thickening in rabbit cuffed carotid artery. Noa M; Más R; Mesa R Pharmacol Res; 2001 Jan; 43(1):31-7. PubMed ID: 11207063 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Desager JP; Horsmans Y Clin Pharmacokinet; 1996 Nov; 31(5):348-71. PubMed ID: 9118584 [TBL] [Abstract][Full Text] [Related]
19. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Jones P; Kafonek S; Laurora I; Hunninghake D Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454 [TBL] [Abstract][Full Text] [Related]
20. Regulation of connexin expression after balloon injury: possible mechanisms for antiproliferative effect of statins. Wang L; Chen J; Sun Y; Zhang F; Zhu J; Hu S; Wang DH Am J Hypertens; 2005 Sep; 18(9 Pt 1):1146-53. PubMed ID: 16245407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]